Southwest Foundation For Biomedical Research Launches For-Profit Drug Company
                   
biospace.com     May 20, 2008          

SAN ANTONIO--(BUSINESS WIRE)--One of the Southwest Foundation for Biomedical Researchs longest running departments is being spun off as a private, for-profit business enterprise based on the massive body of work the department has accumulated in female reproductive and related health issues.SFBR... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics

View other selected articles:

                   

FDA faulted over unapproved uses of medications (AP)

yahoo.com     1 hr ago   1 related          

AP - When federal regulators catch a drug company peddling prescription medications for an unapproved use, it takes them an average of seven months to issue a warning, according to a draft report by congressional investigators.                

comments

Australian journalist faces new Singapore drug charges: court

drugpolicycentral.com     1 hr ago   12 related          

Ketamine is an anaesthetic which has become common at dance parties. He was initially charged with trafficking methamphetamine to a Singaporean at a hotel this month. (Sat Jul 26 22:43:44 2008 PDT)[$drug_related(100%),...                

comments

                   

European Champion Of Nuclear Medicine Is Honored During Society's 55th Annual Meeting

medicalnewstoday.com     1 hr ago          

Peter J. Ell, director of the institute of nuclear medicine and chair of nuclear medicine at the University College London, U.K., was awarded the 2008 Georg Charles de Hevesy Nuclear Pioneer Award for his contributions to the...                

comments

                   

Ceplene® Receives Positive European Opinion For Approval From CHMP - Acute Myeloid Leukemia

medicalnewstoday.com     1 hr ago   7 related          

EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion regarding the...                

comments